Ergomed Enters Strategic Collaboration to Drive Pharmacovigilance Leadership in Intelligent Automation

RNS REACH
PRESS RELEASE

Ergomed Enters Strategic Collaboration to Drive Pharmacovigilance Leadership in Intelligent Automation

PrimeVigilance collaboration with Automation Anywhere and DataRobot to advance
robotic processes and machine learning

Guildford, UK – 18 May 2020: Ergomed plc (LSE: ERGO) ('Ergomed' or the 'Company'), a company focused on providing specialised services to the pharmaceutical industry, is pleased to announce PrimeVigilance’s strategic collaboration with Automation Anywhere, a global leader in Robotic Process Automation (RPA) and DataRobot, the leader in enterprise artificial intelligence (AI), to accelerate the Company’s Intelligent Automation strategy.

PrimeVigilance, a division of Ergomed, is the leading global specialized provider of full pharmacovigilance (PV) services, and currently employs over 750 people. By empowering its clients and colleagues with the application of RPA and Machine Learning (ML), PrimeVigilance will enable clients to improve quality and consistency within safety databases, as well as productivity.

A successful proof of concept has been completed, and PrimeVigilance will now implement a cloud software solution to automate specific pharmacovigilance processes. The productivity gains made possible by working with Automation Anywhere and DataRobot, are expected to deliver organic growth more efficiently, with the automation of manual, repetitive processes. Automation Anywhere’s cloud-based RPA on its digital workforce platform combined with DataRobot’s enterprise AI platform will bring new levels of speed and intelligence to a crucial component of the business, freeing up valuable hours for highly trained pharmacovigilance professionals to focus on value creation and problem solving that only humans can address.

This strategic partnership will be part of Ergomed’s wider strategy as it transforms the relationship between its people and technology, enhancing the Company’s creativity, agility and skills for the benefit of its clients and shareholders. It will enhance Ergomed’s existing skills and expertise by combining human insight and knowledge with the intelligent application of technology to enhance the speed and precision of analysis and decision making.

Dr Miroslav Reljanović, Executive Chairman of Ergomed, said: “Adoption of the latest available technologies, including automation and robotic technology across our pharmacovigilance business, ensures we are able to continue to offer cutting edge services to our customers. This collaboration provides the foundation to rapidly identify and automate a wide range of business processes, enabling clients to maximise quality and consistency within safety databases as well as increasing productivity.”